DEUTSCHE BANK AG\ - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 34 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q4 2019$5,000
-81.5%
1,250
-73.5%
0.00%
Q3 2019$27,000
-85.2%
4,717
-83.6%
0.00%
Q2 2019$182,000
+139.5%
28,702
+119.1%
0.00%
Q1 2019$76,000
+5.6%
13,100
+8.0%
0.00%
Q4 2018$72,000
-65.6%
12,127
-67.2%
0.00%
Q3 2018$209,000
-27.9%
36,942
-22.1%
0.00%
Q2 2018$290,000
+108.6%
47,418
+125.7%
0.00%
Q1 2018$139,000
-4.8%
21,008
+5.2%
0.00%
Q4 2017$146,000
+14.1%
19,973
+8.5%
0.00%
Q3 2017$128,000
+70.7%
18,405
+69.9%
0.00%
Q2 2017$75,000
+476.9%
10,830
+422.7%
0.00%
Q1 2017$13,000
-38.1%
2,072
-47.9%
0.00%
Q4 2016$21,000
+200.0%
3,974
+134.9%
0.00%
Q3 2016$7,000
+75.0%
1,692
+48.6%
0.00%
Q2 2016$4,0000.0%1,139
+18.8%
0.00%
Q1 2016$4,000
+33.3%
959
+19.9%
0.00%
Q4 2015$3,000
-40.0%
800
-9.7%
0.00%
Q3 2015$5,000
-95.9%
886
-94.8%
0.00%
Q2 2015$122,000
-9.0%
17,185
-15.3%
0.00%
Q1 2015$134,000
+74.0%
20,281
+55.8%
0.00%
Q4 2014$77,000
+2466.7%
13,014
+1759.1%
0.00%
Q3 2014$3,000
-96.1%
700
-95.9%
0.00%
Q2 2014$76,000
-1.3%
17,019
-1.5%
0.00%
Q1 2014$77,000
-4.9%
17,277
+7.3%
0.00%
Q4 2013$81,000
+12.5%
16,109
-0.9%
0.00%
Q3 2013$72,00016,2510.00%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q3 2018
NameSharesValueWeighting ↓
BRIDGEWAY CAPITAL MANAGEMENT, LLC 286,655$541,7780.01%
Renaissance Technologies 555,763$1,0500.00%
Oakworth Capital, Inc. 3,052$5,7680.00%
ACADIAN ASSET MANAGEMENT LLC 188,164$3540.00%
MORGAN STANLEY 11,274$21,3080.00%
BlackRock Inc. 110,990$209,7710.00%
Bank of New York Mellon Corp 75,268$142,2560.00%
Citadel Advisors 32,400$61,2360.00%
Citadel Advisors 6,400$12,0960.00%
Citadel Advisors 5,933$11,2130.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders